Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RAPT Therapeutics (RAPT) Non Operating Income: 2018-2023

Historic Non Operating Income for Therapeutics (RAPT) over the last 6 years, with Dec 2023 value amounting to $10.3 million.

  • Therapeutics' Non Operating Income rose 58.18% to $2.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $10.3 million, marking a year-over-year increase of 424.48%. This contributed to the annual value of $10.3 million for FY2023, which is 424.48% up from last year.
  • Per Therapeutics' latest filing, its Non Operating Income stood at $10.3 million for FY2023, which was up 424.48% from $2.0 million recorded in FY2022.
  • In the past 5 years, Therapeutics' Non Operating Income registered a high of $10.3 million during FY2023, and its lowest value of $5,000 during FY2021.
  • Its 3-year average for Non Operating Income is $4.1 million, with a median of $2.0 million in 2022.
  • As far as peak fluctuations go, Therapeutics' Non Operating Income slumped by 99.62% in 2021, and later soared by 39,040.00% in 2022.
  • Over the past 5 years, Therapeutics' Non Operating Income (Yearly) stood at $1.3 million in 2019, then climbed by 1.55% to $1.3 million in 2020, then slumped by 99.62% to $5,000 in 2021, then skyrocketed by 39,040.00% to $2.0 million in 2022, then spiked by 424.48% to $10.3 million in 2023.